THERAPEUTIC AGENT AND INSPECTION METHOD FOR DISEASES CAUSED BY NEUTROPHIL ACTIVATION

摘要

PROBLEM TO BE SOLVED: To provide a therapeutic agent for diseases caused by neutrophil activation, the therapeutic agent containing a neutrophil activation regulatory agent which has a neutrophil activation controlling function and a neutrophil activation regulating function; and also to provide an inspection method for diseases caused by neutrophil activation.SOLUTION: The invention provides a therapeutic agent for inflammatory diseases associated with neutrophil activation the therapeutic agent using a neutrophil activation regulatory agent containing a histidine rich glycoprotein (HRG) as an active ingredient, and a neutrophil-endothelial cell interaction inhibitor containing the HRG as an active ingredient; and an inspection method for inflammatory diseases associated with neutrophil activation by measuring the amount of HRG in blood.SELECTED DRAWING: Figure 13